4-pyridazinecarboxamides and esters as interleukin-1β converting enzyme inhibitors
US6995261B2 · kind B2 · utility
0Cited by
7References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 22, 2003 |
| Grant date | Feb 7, 2006 |
| Priority date | — |
| Expiry date | Sep 22, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are compounds of the formula (I) and pharmaceutically acceptable salts thereof: wherein
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.